GNH USA

Europe — EMA

Memantin 1a Pharma

GNH USA supplies Memantin 1a Pharma (Memantine Hydrochloride), a NMDA receptor antagonist for moderate to severe Alzheimer’s disease.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine Hydrochloride, the active ingredient in Memantin 1a Pharma, is a NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to improve cognition, memory, and functional abilities and may slow disease progression.

GNH USA supplies Memantin 1a Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

What is Memantine Hydrochloride used for?

Memantine Hydrochloride is used in the management of Alzheimer’s disease, targeting glutamatergic neurotransmission to address cognitive decline.

- Moderate to severe Alzheimer’s disease: improves cognition, memory, and daily functional abilities. - Mild to moderate Alzheimer’s disease (adjunct therapy): may support overall cognitive performance when combined with cholinesterase inhibitors. - Behavioral symptoms of Alzheimer’s disease: may reduce agitation and improve patient cooperation.

What are the side effects of Memantine Hydrochloride?

Memantine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion - Nausea

Serious or Rare Side Effects: - Severe allergic reaction (rash, swelling, difficulty breathing) - Seizures - Hallucinations or psychosis - High blood pressure (hypertension) - Liver function abnormalities - Suicidal thoughts or behavior

What precautions apply to Memantine Hydrochloride?

When prescribing memantine, clinicians should consider several safety precautions to minimize risks.

- Renal impairment: adjust dose or monitor renal function regularly. - Hepatic dysfunction: use with caution and assess liver enzymes. - Concomitant CNS depressants: monitor for enhanced sedation or dizziness. - History of seizures: evaluate risk as memantine may lower seizure threshold. - Pregnancy and breastfeeding: avoid use unless benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

What does Memantine Hydrochloride interact with?

Memantine can interact with other medicines, affecting its safety or effectiveness.

Major Interactions (Avoid): - Other NMDA antagonists (e.g., amantadine, ketamine): may increase neuropsychiatric adverse effects. - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce memantine plasma levels.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish cognitive benefits of memantine. - CNS depressants (e.g., benzodiazepines, opioids): may enhance dizziness or sedation. - Diuretics: may increase risk of hypotension when combined with memantine.

Frequently asked questions

What is Memantin 1a Pharma used for?+
Memantin 1a Pharma contains memantine hydrochloride and is prescribed for the symptomatic treatment of moderate to severe Alzheimer’s disease. It helps to improve cognitive function, memory, and daily living activities by modulating abnormal glutamate activity in the brain.
How does Memantine Hydrochloride work?+
Memantine Hydrochloride works as a non‑competitive antagonist of the NMDA receptor ion channel. By blocking excessive calcium influx caused by prolonged glutamate stimulation, it reduces excitotoxic neuronal damage while allowing normal synaptic transmission, which supports neuronal stability in Alzheimer’s disease.
What is the usual dose of Memantin 1a Pharma?+
The dosage of Memantin 1a Pharma is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. The prescriber will set the appropriate strength and titration schedule according to approved guidelines.
Is Memantin 1a Pharma safe during pregnancy or breastfeeding?+
Safety data for memantine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Memantin 1a Pharma from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Memantin compare with the main alternative drug or class?+
The primary alternative class for Alzheimer’s disease is cholinesterase inhibitors (e.g., donepezil). While cholinesterase inhibitors increase acetylcholine levels, memantine modulates glutamate activity. Both can be used together for additive benefit, but memantine is typically reserved for moderate to severe stages where cholinesterase inhibitors alone may be insufficient.
What are the storage and handling requirements for Memantin 1a Pharma?+
Memantin 1a Pharma tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains sealed until use.
How is Memantin 1a Pharma administered?+
Memantin 1a Pharma is taken orally, usually with water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable plasma levels. Patients should follow the prescriber’s instructions regarding titration and timing.
What are the most serious risks to watch for while taking Memantin?+
Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), seizures, hallucinations or psychosis, and marked hypertension. Patients should seek immediate medical attention if any of these symptoms develop.
Who should not use Memantin 1a Pharma?+
Memantin should be avoided in patients with known hypersensitivity to memantine or any excipients, in those with uncontrolled severe renal impairment without dose adjustment, and in pregnant or breastfeeding women unless the benefit justifies the potential risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
1a Pharma Gmbh
Origin
EU

Related products